Skip to main content

24 January 2022

Last updated: Thursday 20 January 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Commentary: Thought disruption in R&D discovery

Tuesday 27 December 2016

Interviewee/Contributor

Tony Sedgwick

Organisation

Novasecta Ltd

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributor

Tony Sedgwick

Organisation

Novacta Biosystems Ltd

Organisations

Cellular Dynamics International Inc
Acesion Pharma ApS
Genenta Science SpA
University of Pennsylvania, Perelman School of Medicine
Theragnostics Ltd
Araris Biotech AG
Chroma Therapeutics Ltd
Biotec Pharmacon ASA
Sidley Austin LLP
Forbion

Interviewees and Contributers

Paul Thompson
Jacques Thèze
Edwin Moses
Pawel Świeboda
Lita Nelsen
Herve Brailly
Richard Pops
Clare Ozawa
Dr Tim Andrews
Thomas Lönngren

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Anders Tullgren joins BerGenBio

Thursday 13 January 2022

BiVictriX Therapeutics appoints CFO

Thursday 13 January 2022

Faron appoints new CMO

Thursday 13 January 2022

MiNA Therapeutics appoints directors

Thursday 13 January 2022

Agomab expands leadership team

Thursday 13 January 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form